P210 Intestinal mucosal calprotectin (iMC) in ulcerative colitis (UC): measuring disease activity, defining remission and predicting outcome

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

“…Measurement of faecal calprotectin might have enhanced the study. However, retrospective analysis of mucosal calprotectin in this cohort was not associated with outcomes,59 and another group has been unable to correlate faecal calprotectin and histological activity, even if a low calprotectin was associated with a better clinical outcome 60…”